ArticleRisk management and healthcare policy2025
Experience of Symptoms Related to Dysarthria in Patients with NPC During Radiotherapy: A Descriptive Qualitative Study.
Article in Risk management and healthcare policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Radiation to the adjacent parts of the tumor and radiation to the larynx may lead to voice changes and the development of dysarthria, however, dysarthria is often overlooked compared to other complications. It is necessary to understand the experience of nasopharyngeal cancer (NPC) patients with symptoms related to dysarthria after radiotherapy. Methods: This qualitative descriptive study enrolled 33 patients NPC radiotherapy patients who experienced dysarthria were recruited from May to August 2024. Data were collected using semi-structured interviews. The interviews were audio-recorded and converted verbatim into standard text, and the data were iteratively thematically analyzed. Results: Changes in speech and language quality after radiotherapy for NPC are common, but there are differences in the degree of symptoms perceived by patients. At the same time, dysarthria is often accompanied by other diverse oropharyngeal symptoms, and the trajectory-varying nature of these symptom experiences imposes a dual physical and psychological burden on patients. Lack of awareness of dysarthria and inadequate emotional support may lead to very different coping styles and a desire for professional ongoing voice management. Conclusion: This study helps to elucidate the current status of dysarthria faced by patients undergoing radiotherapy for NPC and provides multiple dimensions of dysarthria assessment and management goals for quantitative research. We call attention to the need for healthcare professionals to pay attention to patients' perspectives and related needs and to develop targeted management strategies that match patients' needs, and we emphasize the importance of continuity of care to effectively improve dysarthria-related symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.